The HHS’ rule 0936-AA08 is delayed for almost two years

The U.S. District Court for the District of Columbia has issued a court order delaying the Department of Health and Human Services’ rule 0936-AA08 for almost two years. The prior administration rule would have altered payments from drugmakers to pharmacy middlemen –pharmacy benefit managers (PBMs) such that they can’t fluctuate based on the price of a drug. However, the drug companies say the current system forces them to keep prices high because PBMs who help decide how a drug will be covered by insurance demand high discounts to give products preferential treatment. Read the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org